0,696  0,019  Antineoplastic (lung cancer)
0,573  0,026  Antineoplastic (colorectal cancer)
0,570  0,028  Antileukemic
0,564  0,025  Antineoplastic (colon cancer)
0,541  0,013  Antineoplastic (glioma)
0,525  0,009  Acute neurologic disorders treatment
0,530  0,015  Antineoplastic (non-small cell lung cancer)
0,535  0,022  Stroke treatment
0,542  0,045  Antineoplastic (breast cancer)
0,509  0,013  Antineoplastic (glioblastoma multiforme)
0,489  0,004  Mediator release inhibitor
0,493  0,025  Antineoplastic (melanoma)
0,480  0,022  Antimycobacterial
0,480  0,030  Antineoplastic (ovarian cancer)
0,460  0,022  Antituberculosic
0,485  0,066  Caspase 9 stimulant
0,446  0,028  Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor
0,490  0,078  Apoptosis agonist
0,415  0,019  Antineoplastic (osteosarcoma)
0,408  0,014  Antineoplastic (bladder cancer)
0,413  0,021  Antineoplastic (renal cancer)
0,421  0,033  Antineoplastic (cervical cancer)
0,425  0,064  5 Hydroxytryptamine release inhibitor
0,426  0,065  Antibacterial
0,408  0,050  Prostate cancer treatment
0,418  0,069  Calcium channel L-type activator
0,373  0,027  Antimitotic
0,387  0,041  Antineoplastic (pancreatic cancer)
0,378  0,033  DNA damaging
0,419  0,085  Ca2+/calmodulin-dependent protein kinase kinase A inhibitor
0,376  0,047  AR expression inhibitor
0,393  0,065  GABA C receptor rho-3 antagonist
0,348  0,025  Antineoplastic (sarcoma)
0,362  0,053  Aldehyde oxidase inhibitor
0,347  0,047  UGT1A9 substrate
0,301  0,019  Tubulin antagonist
0,307  0,041  Antineoplastic (lymphocytic leukemia)
0,283  0,021  Lipid peroxidase inhibitor
0,277  0,017  Pancreatic disorders treatment
0,321  0,065  Antineoplastic (brain cancer)
0,281  0,036  RNA-directed DNA polymerase inhibitor
0,308  0,067  CTGF expression inhibitor
0,263  0,023  Topoisomerase II inhibitor
0,337  0,098  Antipruritic, allergic
0,331  0,092  Ulceration
0,253  0,016  Topoisomerase I inhibitor
0,254  0,020  Heat shock protein 90 antagonist
0,296  0,062  Aryl hydrocarbon receptor agonist
0,284  0,056  Cytostatic
0,245  0,017  DNA intercalator
0,283  0,064  Chemoprotective
0,276  0,063  NOS2 expression inhibitor
0,273  0,063  Antineoplastic (liver cancer)
0,232  0,035  Antineoplastic (carcinoma)
0,257  0,064  Antineoplastic (lymphoma)
0,290  0,102  Calcium channel activator
0,207  0,023  Cystathionine beta-synthase inhibitor
0,222  0,038  Heat shock protein 90 alpha antagonist
0,208  0,027  MAO A inhibitor
0,243  0,064  Cytotoxic
0,287  0,108  Antiprotozoal (Plasmodium)
0,261  0,084  GST M1-1 substrate
0,215  0,037  VEGF expression inhibitor
0,222  0,046  Mcl-1 antagonist
0,299  0,124  Histamine release inhibitor
0,219  0,046  Dual specificity phosphatase inhibitor
0,215  0,043  Antineoplastic (gastric cancer)
0,238  0,067  UGT1A6 substrate
0,198  0,030  GABA C receptor rho-2 antagonist
0,223  0,057  Nitric-oxide synthase stimulant
0,178  0,012  NAD(P)H dehydrogenase (quinone) inhibitor
0,283  0,120  CYP2C9 substrate
0,256  0,092  Antineoplastic (multiple myeloma)
0,179  0,016  Antineoplastic (uterine cancer)
0,243  0,087  Antioxidant
0,245  0,090  Radiosensitizer
0,215  0,061  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,213  0,063  Pneumotoxic
0,318  0,170  Antineoplastic (solid tumors)
0,191  0,043  MAO inhibitor
0,191  0,045  Phobic disorders treatment
0,240  0,094  Huntington's disease treatment
0,197  0,055  Antimutagenic
0,274  0,132  Immunosuppressant
0,179  0,041  NADPH oxidase inhibitor
0,217  0,080  MAP kinase kinase 3 inhibitor
0,222  0,090  Cardiovascular analeptic
0,155  0,024  Caspase 3 inhibitor
0,194  0,065  Antipruritic, non-allergic
0,215  0,086  Antiviral (West Nile virus)
0,177  0,051  Hexokinase inhibitor
0,184  0,060  Antirickettsial
0,179  0,054  Antiviral (Influenza A)
0,151  0,031  Photosensitizer
0,130  0,012  HIV-1 integrase inhibitor
0,269  0,152  TNF expression inhibitor
0,247  0,131  FMO1 substrate
0,219  0,103  Proliferative diseases treatment
0,171  0,056  UGT2B15 substrate
0,215  0,101  DNA synthesis inhibitor
0,157  0,046  Glutamate receptor antagonist
0,218  0,107  Tyrosine 3 hydroxylase inhibitor
0,174  0,063  UGT2B10 substrate
0,170  0,060  Cyclin-dependent kinase 3 inhibitor
0,222  0,114  UGT2B4 substrate
0,189  0,080  UGT1A1 substrate
0,141  0,033  Antineoplastic antibiotic
0,200  0,093  Cyclic AMP phosphodiesterase inhibitor
0,152  0,045  Alkylator
0,172  0,068  Peroxidase inhibitor
0,247  0,146  Antineoplastic (small cell lung cancer)
0,169  0,069  UGT1A3 substrate
0,128  0,028  Topoisomerase II alpha inhibitor
0,140  0,041  MAO B inhibitor
0,219  0,122  Lipoxygenase inhibitor
0,194  0,097  Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor
0,146  0,052  Ca2+-transporting ATPase inhibitor
0,138  0,044  DNA repair enzyme inhibitor
0,131  0,043  Antifungal (Pneumocystis)
0,115  0,027  Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor
0,217  0,129  Antihypoxic
0,111  0,024  Cyclin B3 inhibitor
0,213  0,128  5 Hydroxytryptamine uptake stimulant
0,249  0,165  Antiprotozoal
0,095  0,013  Heat shock protein 90 beta antagonist
0,148  0,066  Mannose-6-phosphate isomerase inhibitor
0,216  0,134  Hypoxia-inducible factor 1 alpha inhibitor
0,128  0,046  NAT2 substrate
0,183  0,105  Ca2+/calmodulin-dependent kinase I alpha inhibitor
0,175  0,097  Pyruvate kinase inhibitor
0,161  0,084  Death-associated protein kinase 2 inhibitor
0,193  0,117  Antihypotensive
0,245  0,169  15-Lipoxygenase inhibitor
0,185  0,110  Age-related macular degeneration treatment
0,143  0,069  Antineoplastic (squamous cell carcinoma)
0,168  0,095  UDP-glucuronosyltransferase substrate
0,130  0,060  Coagulant
0,076  0,005  DNA gyrase subunit A inhibitor
0,148  0,080  Aldose reductase substrate
0,087  0,020  Glutamate (mGluR7) antagonist
0,181  0,114  Free radical scavenger
0,114  0,048  Antineoplastic, alkylator
0,200  0,133  CYP2C19 substrate
0,129  0,063  Aldehyde dehydrogenase inhibitor
0,098  0,034  Telomerase inhibitor
0,175  0,114  Dyrk kinase inhibitor
0,162  0,103  Antiviral (Influenza)
0,145  0,085  Chemopreventive
0,154  0,095  ATPase inhibitor
0,143  0,085  UGT2B9 substrate
0,213  0,157  Transcription factor NF kappa B inhibitor
0,102  0,046  NMDA receptor antagonist
0,203  0,148  12-Lipoxygenase inhibitor
0,121  0,068  Contraceptive female
0,075  0,023  Transcription factor RelA inhibitor
0,136  0,085  Genotoxic
0,154  0,104  Succinate dehydrogenase inhibitor
0,141  0,091  Mutagenic
0,185  0,135  Interleukin agonist
0,199  0,149  Antifungal
0,142  0,092  UGT1A4 substrate
0,101  0,052  Falcipain 2 inhibitor
0,193  0,144  Transcription factor STAT3 inhibitor
0,101  0,054  Falcipain inhibitor
0,084  0,039  CDC25A inhibitor
0,143  0,099  Hearing loss treatment
0,053  0,011  Caspase 2 inhibitor
0,072  0,031  NMDA 2C receptor antagonist
0,104  0,064  Carcinogenic, group 2B
0,138  0,099  CF transmembrane conductance regulator agonist
0,069  0,030  Cyclin D1 inhibitor
0,197  0,159  CYP1A2 substrate
0,135  0,097  Heat shock protein 70 antagonist
0,051  0,014  Inosine monophosphate dehydrogenase inhibitor
0,050  0,014  p53 inhibitor
0,088  0,052  Antiviral (Trachoma)
0,085  0,051  Caspase 7 inhibitor
0,114  0,080  Antiviral (Influenza B)
0,092  0,058  Polo-like kinase-1 inhibitor
0,209  0,175  CYP3A4 substrate
0,090  0,058  Antidote, mercury
0,088  0,056  Granulocyte macrophage colony stimulating factor agonist
0,087  0,056  Carcinogenic, group 2A
0,119  0,090  Antifungal enhancer
0,117  0,090  Antihemorrhagic
0,117  0,091  Papain-like protease (SARS coronavirus) inhibitor
0,133  0,108  Melanin inhibitor
0,061  0,038  Bcl-xL inhibitor
0,065  0,043  CDC25B inhibitor
0,127  0,106  UGT2B7 substrate
0,134  0,113  Carcinogenic, group 1
0,160  0,139  Antiviral (HIV)
0,067  0,047  Antihemophilic
0,049  0,030  Aldosterone antagonist
0,163  0,144  Immunostimulant
0,099  0,080  Antifungal (Aspergillus)
0,199  0,180  Apoptosis antagonist
0,092  0,074  GABA C receptor rho-1 antagonist
0,098  0,082  SULT1A1 substrate
0,084  0,068  Bromodomain-containing protein 2 inhibitor
0,073  0,059  Keratolytic
0,056  0,043  Pregnane X receptor antagonist
0,030  0,019  Thiazolidinedione
0,059  0,048  5 Hydroxytryptamine 2A agonist
0,129  0,120  Ca2+/calmodulin-dependent protein kinase kinase B inhibitor
0,106  0,097  Antiprotozoal (Amoeba)
0,098  0,089  Carcinogenic, group 3
0,079  0,071  mTOR complex 2 inhibitor
0,090  0,083  Ferrochelatase inhibitor
0,098  0,092  Acetylcholine release stimulant
0,191  0,184  Caspase 3 stimulant
0,068  0,061  NAT1 substrate
0,165  0,159  5 Hydroxytryptamine release stimulant
0,051  0,046  Beta tubulin antagonist
0,072  0,067  Xanthine oxidase substrate
0,108  0,103  Alkaline phosphatase inhibitor
0,087  0,083  UGT2B11 substrate
0,145  0,142  Antiulcerative
0,054  0,050  Androgen agonist
0,073  0,070  ALK inhibitor
0,050  0,048  Cyclin B2 inhibitor
0,018  0,016  Inosine monophosphate dehydrogenase 1 inhibitor
0,088  0,087  Estrogen receptor beta antagonist
0,182  0,182  Cholesterol antagonist

